These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12894224)

  • 1. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
    Xin H; Curry J; Johnstone RW; Nickoloff BJ; Choubey D
    Oncogene; 2003 Jul; 22(31):4831-40. PubMed ID: 12894224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IFI 16 in cellular senescence of human fibroblasts.
    Xin H; Pereira-Smith OM; Choubey D
    Oncogene; 2004 Aug; 23(37):6209-17. PubMed ID: 15208661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
    Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
    Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
    Dawson MJ; Trapani JA
    J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
    Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
    Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.
    Schwarze SR; Shi Y; Fu VX; Watson PA; Jarrard DF
    Oncogene; 2001 Dec; 20(57):8184-92. PubMed ID: 11781834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
    Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
    Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
    Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
    Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescence.
    Clarke CJ; Hii LL; Bolden JE; Johnstone RW
    J Cell Biochem; 2010 Jan; 109(1):103-12. PubMed ID: 19885868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFI16 in human prostate cancer.
    Alimirah F; Chen J; Davis FJ; Choubey D
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation.
    Brenner AJ; Stampfer MR; Aldaz CM
    Oncogene; 1998 Jul; 17(2):199-205. PubMed ID: 9674704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL; Herrera RE; Yee D
    Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer.
    Untergasser G; Koch HB; Menssen A; Hermeking H
    Cancer Res; 2002 Nov; 62(21):6255-62. PubMed ID: 12414655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the p21 sdi1 gene induces senescence-like state in human cancer cells: implication for senescence-directed molecular therapy for cancer.
    Kagawa S; Fujiwara T; Kadowaki Y; Fukazawa T; Sok-Joo R; Roth JA; Tanaka N
    Cell Death Differ; 1999 Aug; 6(8):765-72. PubMed ID: 10467350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.